GSKpro for UK healthcare professionals
Ordering and delivery
DECTOVA▼
Contact | GSKpro UK
Report a possible side effect | GSKpro
Request a contact
Therapy areas | GSKpro UK
VENTOLIN
FLIXOTIDE
BLENREP▼
Ellipta critical error studies in COPD
XEVUDY ▼ (sotrovimab)
JEMPERLI ▼ (Dostarlimab (FOR NI HCP’s ONLY))
JEMPERLI ▼ (Dostarlimab (FOR GB HCP’s ONLY))
Coming soon | GSKpro
Respiratory
Vaccines
GSKpro Home | SHINGRIX
Immunocompromised | SHINGRIX
Immunocompromised Clinical Data | SHINGRIX
GSKpro Implementation | SHINGRIX
GSKpro Impact of Shingles | SHINGRIX
GSKpro SHINGRIX overview | SHINGRIX
GSKpro Efficacy | SHINGRIX
GSKpro Safety | SHINGRIX
Discontinued products | GSK Pro
Therapy areas | GSKpro UK
AREXVY▼
OMJJARA▼
Products | GSKpro
ZEJULA
This summer, how can GSK help you deliver the non-seasonal shingles National Immunisation Programme?
Get in touch | OMJJARA▼ (momelotinib) UK
GSKpro Arexvy ▼ | Product Information for Healthcare Professionals
ZEJULA (niraparib)
Efficacy | ZEJULA (niraparib)
PRIMA Study design
PRIME Study design
PRIMA PFS
PRIME PFS
PRIMA Overview
Safety Profile | ZEJULA (niraparib)
PRIMA Reported TEAE's
PRIME study overview
PRIMA Safety profile
Zejula Required Monitoring
PRIME Reported TEAE's
PRIME Safety profile
Quality of life | ZEJULA (niraparib)
QoL
Recommended dosing
Dosing | ZEJULA (niraparib)
Dosing | ZEJULA (niraparib)
ZEJULA (niraparib) MoA
Webinars & events | GSKpro
Supply
Resources | GSKpro
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.